A serotonin-induced N-glycan switch regulates platelet aggregation
Open Access
- 30 September 2013
- journal article
- research article
- Published by Springer Science and Business Media LLC in Scientific Reports
- Vol. 3 (1), 2795
- https://doi.org/10.1038/srep02795
Abstract
Serotonin (5-HT) is a multifunctional signaling molecule that plays different roles in a concentration-dependent manner. We demonstrated that elevated levels of plasma 5-HT accelerate platelet aggregation resulting in a hypercoagulable state in which the platelet surface becomes occupied by several glycoproteins. Here we study the novel hypothesis that an elevated level of plasma 5-HT results in modification of the content of N-glycans on the platelet surface and this abnormality is associated with platelet aggregation. Mass spectrometry of total surface glycoproteins on platelets isolated from wild-type mice infused for 24 hours with saline or 5-HT revealed that the content of glycoproteins on platelets from 5-HT-infused mice switched from predominantly N-acetyl-neuraminic acid (Neu5Ac) to N-glycolyl-neuraminic acid (Neu5Gc). Cytidine monophosphate-N-acetylneuraminate hydroxylase (CMAH) synthesizes Neu5Gc from Neu5Ac. Up-regulation of Neu5Gc content on the platelet surface resulted from an increase in the catalytic function, not expression, of CMAH in platelets of 5-HT-infused mice. The highest level of Neu5Gc was observed in platelets of 5-HT-infused, 5-HT transporter-knock out mice, suggesting that the surface delineated 5-HT receptor on platelets may promote CMAH catalytic activity. These new findings link elevated levels of plasma 5-HT to altered platelet N-glycan content, a previously unrecognized abnormality that may favor platelet aggregation.This publication has 53 references indexed in Scilit:
- Impact of Elevated Plasma Serotonin on Global Gene Expression of Murine MegakaryocytesPLOS ONE, 2013
- Down-regulation of the serotonin transporter in hyperreactive platelets counteracts the pro-thrombotic effect of serotoninJournal of Molecular and Cellular Cardiology, 2012
- Targeted inhibition of the serotonin 5HT2A receptor improves coronary patency in an in vivo model of recurrent thrombosisJournal of Thrombosis and Haemostasis, 2010
- Evidence for a novel human-specific xeno-auto-antibody response against vascular endotheliumBlood, 2009
- Beneficial Effects of Sarpogrelate Hydrochloride, a 5-ht2aReceptor Antagonist, Supplemented with Pioglitazone on Diabetic Model MiceEndocrine Research, 2009
- Drugs and Valvular Heart DiseaseNew England Journal of Medicine, 2007
- Inhibition of 5‐hydroxytryptamine2A receptor prevents occlusive thrombus formation on neointima of the rabbit femoral arteryJournal of Thrombosis and Haemostasis, 2005
- CMP‐N‐acetylneuraminic acid hydroxylase from mouse liver and pig submandibular glandsJBIC Journal of Biological Inorganic Chemistry, 1994
- Reconstitution of 5-hydroxytryptamine transport from cholate-disrupted platelet plasma membrane vesiclesBiochemistry, 1978